Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Karim Dorgham and Avidan Neumann.
Karim Dorgham
Connection Strength
0.709
Avidan Neumann
  1. Tocilizumab in COVID-19 therapy: who benefits, and how? Lancet. 2021 07 24; 398(10297):299-300.
    View in: PubMed
    Score: 0.240
  2. Distinct cytokine profiles associated with COVID-19 severity and mortality. J Allergy Clin Immunol. 2021 06; 147(6):2098-2107.
    View in: PubMed
    Score: 0.235
  3. Considering Personalized Interferon Beta Therapy for COVID-19. Antimicrob Agents Chemother. 2021 03 18; 65(4).
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.